© 2025 MJH Life Sciences™ and Patient Care Online. All rights reserved.
AIDS Reader
Articles
Neuropsychiatric Aspects of Coinfection With HIV and Hepatitis C Virus
August 01, 2008
In the United States, an estimated 150,000 to 300,000 people are infected with both HIV and hepatitis C virus (HCV), representing about 15% to 30% of all persons living with HIV infection1,2 and 70% to 90% of injection drug users
Editorial Comment: Neuropsychiatric Aspects of HIV/HCV Coinfection-What Every HIV Care Provider Needs to Know and Address
August 01, 2008
The HIV epidemic was discovered in the early 1980s, and the response from the medical community was remarkable. Health care providers committed their time and careers to the cause of a group of people afflicted with an unknown and fatal illness.
HPV-Linked Oral Cancer: Another Argument for Universal HPV Vaccination of Boys and Girls
July 02, 2008
Five years ago, the International Agency for Research on Cancer (IARC) conducted a case-control study in 9 sites (Italy, Spain, Northern Ireland, Poland, India, Cuba, Canada, Australia, and Sudan) of 1415 participants with cancer of the oral cavity and 255 with oropharyngeal carcinoma.1 Markers for human papillomavirus (HPV) infection were evaluated, including antibodies against HPV16 E6 and E7 proteins, which are common in cervical cancer, and HPV DNA in biopsy samples, detected by polymerase chain reaction assay.
Severe Headaches and Cerebrovascular Disease in a Young Man With Perinatally Acquired HIV Infection
July 02, 2008
Cerebrovascular disease (CVD) in HIV may be associated with multiple concurrent etiologies and with varying presentations, from chronic asymptomatic microvascular calcifications or vascular anomalies to intracerebral hemorrhage to thrombotic stroke.
Hormonal Contraception in HIV-Positive Women
July 02, 2008
In September 2006, the CDC recommended that the interpretation of "general consent" for medical care include HIV screening, which eliminated the need for a separate, written consent.
Status Epilepticus Resulting From Severe Efavirenz Toxicity in an HIV-Infected Patient
July 01, 2008
We present the case of an HIV-infected patient with cirrhosis in whom severe neuropsychiatric signs and symptoms developed in the setting of a significantly elevated plasma efavirenz level.
HIV-Associated Osteonecrosis of the Hip
July 01, 2008
A 40-year-old homosexual man with CDC class B3 HIV infection presented to our clinic complaining of worsening right hip pain. HIV infection had been diagnosed in 1995. His most recent CD4+ cell count was 167/µL, and his HIV RNA level was suppressed while he was receiving antiretroviral therapy consisting of emtricitabine/tenofovir fixed-dose combination, efavirenz, and ritonavir-boosted atazanavir.
Effect of Patient Adherence to Antiretroviral Therapy on the Progression of Cervical Dysplasia Among HIV-Infected Women
July 01, 2008
A case-control study was conducted that involved a retrospective chart review of 181 HIV-infected women in whom cervical dysplasia had been diagnosed to examine the association between patient adherence to highly active antiretroviral therapy and the regression or stabilization of cervical dysplasia.
Initial Regimens for the Treatment-Naive Patient: Current Understanding and Practice
June 02, 2008
Since the introduction of highly active antiretroviral therapy in the mid-1990s, antiretroviral therapy (ART) options have expanded considerably to include simpler, safer, and more tolerable regimens.
Using the Galactomannan Assay in the Diagnosis of Invasive Aspergillosis
June 02, 2008
Aspergillus species are ubiquitous molds to which humans are commonly exposed. Of approximately 180 species, it is estimated that 34 are medically significant. Most persons who come in contact with the fungus remain asymptomatic.